Global Rare Disease Genetic Testing Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 107784
  • calendar_today Published On: Sep, 2020
  • file_copy Pages: 156
  • list Services
Buy @ $3500

Market Overview

The Rare Disease Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Rare Disease Genetic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation

Rare Disease Genetic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Rare Disease Genetic Testing market has been segmented into Next-Generation Sequencing (NGS), Array Technology, PCR-based Testing, Fluorescence in Situ Hybridization (FISH), Sanger Sequencing, Karyotyping, Others, etc.

Breakdown by Application, Rare Disease Genetic Testing has been segmented into Research Laboratories and CROs, Diagnostic Laboratories, Hospitals and Clinics, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Rare Disease Genetic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Rare Disease Genetic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rare Disease Genetic Testing market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Rare Disease Genetic Testing Market Share Analysis

Rare Disease Genetic Testing competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Rare Disease Genetic Testing revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rare Disease Genetic Testing revenue and market share for each player covered in this report.

The major players covered in Rare Disease Genetic Testing are: Quest Diagnostics, Ambry Genetics, 3billion, Centogene, Strand Life Sciences, Invitae Corporation, Macrogen, Eurofins Scientific, Arup Laboratories, Perkin Elmer, Coopersurgical, LabCorp, Baylor Genetics, Fulgent Genetics, Progenity, Color Genomics, Opko Health, Myriad Genetics, Preventiongenetics, etc. Among other players domestic and global, Rare Disease Genetic Testing market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Quest Diagnostics

Ambry Genetics

3billion

Centogene

Strand Life Sciences

Invitae Corporation

Macrogen

Eurofins Scientific

Arup Laboratories

Perkin Elmer

Coopersurgical

LabCorp

Baylor Genetics

Fulgent Genetics

Progenity

Color Genomics

Opko Health

Myriad Genetics

Preventiongenetics

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Next-Generation Sequencing (NGS)

Array Technology

PCR-based Testing

Fluorescence in Situ Hybridization (FISH)

Sanger Sequencing

Karyotyping

Others

Market segment by Application, can be divided into

Research Laboratories and CROs

Diagnostic Laboratories

Hospitals and Clinics

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Rare Disease Genetic Testing

1.2 Classification of Rare Disease Genetic Testing by Type

1.2.1 Overview: Global Rare Disease Genetic Testing Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Rare Disease Genetic Testing Revenue Market Share by Type in 2019

1.2.3 Next-Generation Sequencing (NGS)

1.2.4 Array Technology

1.2.5 PCR-based Testing

1.2.6 Fluorescence in Situ Hybridization (FISH)

1.2.7 Sanger Sequencing

1.2.8 Karyotyping

1.2.9 Others

1.3 Global Rare Disease Genetic Testing Market by Application

1.3.1 Overview: Global Rare Disease Genetic Testing Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Research Laboratories and CROs

1.3.3 Diagnostic Laboratories

1.3.4 Hospitals and Clinics

1.3.5 Others

1.4 Global Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

1.5 Global Rare Disease Genetic Testing Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Rare Disease Genetic Testing Market Size by Regions (2015-2020)

1.7 Global Rare Disease Genetic Testing Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Rare Disease Genetic Testing Status and Prospect (2015-2025)

1.7.2 Europe Rare Disease Genetic Testing Status and Prospect (2015-2025)

1.7.3 Asia Rare Disease Genetic Testing Status and Prospect (2015-2025)

1.7.4 South America Rare Disease Genetic Testing Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Rare Disease Genetic Testing Status and Prospect (2015-2025)

2 Company Profiles

2.1 Quest Diagnostics

2.1.1 Quest Diagnostics Details

2.1.2 Quest Diagnostics Major Business

2.1.3 Quest Diagnostics SWOT Analysis

2.1.4 Quest Diagnostics Product and Services

2.1.5 Quest Diagnostics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.2 Ambry Genetics

2.2.1 Ambry Genetics Details

2.2.2 Ambry Genetics Major Business

2.2.3 Ambry Genetics SWOT Analysis

2.2.4 Ambry Genetics Product and Services

2.2.5 Ambry Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.3 3billion

2.3.1 3billion Details

2.3.2 3billion Major Business

2.3.3 3billion SWOT Analysis

2.3.4 3billion Product and Services

2.3.5 3billion Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.4 Centogene

2.4.1 Centogene Details

2.4.2 Centogene Major Business

2.4.3 Centogene SWOT Analysis

2.4.4 Centogene Product and Services

2.4.5 Centogene Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.5 Strand Life Sciences

2.5.1 Strand Life Sciences Details

2.5.2 Strand Life Sciences Major Business

2.5.3 Strand Life Sciences SWOT Analysis

2.5.4 Strand Life Sciences Product and Services

2.5.5 Strand Life Sciences Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.6 Invitae Corporation

2.6.1 Invitae Corporation Details

2.6.2 Invitae Corporation Major Business

2.6.3 Invitae Corporation Product and Services

2.6.4 Invitae Corporation Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.7 Macrogen

2.7.1 Macrogen Details

2.7.2 Macrogen Major Business

2.7.3 Macrogen Product and Services

2.7.4 Macrogen Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.8 Eurofins Scientific

2.8.1 Eurofins Scientific Details

2.8.2 Eurofins Scientific Major Business

2.8.3 Eurofins Scientific Product and Services

2.8.4 Eurofins Scientific Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.9 Arup Laboratories

2.9.1 Arup Laboratories Details

2.9.2 Arup Laboratories Major Business

2.9.3 Arup Laboratories Product and Services

2.9.4 Arup Laboratories Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.10 Perkin Elmer

2.10.1 Perkin Elmer Details

2.10.2 Perkin Elmer Major Business

2.10.3 Perkin Elmer Product and Services

2.10.4 Perkin Elmer Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.11 Coopersurgical

2.11.1 Coopersurgical Details

2.11.2 Coopersurgical Major Business

2.11.3 Coopersurgical Product and Services

2.11.4 Coopersurgical Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.12 LabCorp

2.12.1 LabCorp Details

2.12.2 LabCorp Major Business

2.12.3 LabCorp Product and Services

2.12.4 LabCorp Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.13 Baylor Genetics

2.13.1 Baylor Genetics Details

2.13.2 Baylor Genetics Major Business

2.13.3 Baylor Genetics Product and Services

2.13.4 Baylor Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.14 Fulgent Genetics

2.14.1 Fulgent Genetics Details

2.14.2 Fulgent Genetics Major Business

2.14.3 Fulgent Genetics Product and Services

2.14.4 Fulgent Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.15 Progenity

2.15.1 Progenity Details

2.15.2 Progenity Major Business

2.15.3 Progenity Product and Services

2.15.4 Progenity Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.16 Color Genomics

2.16.1 Color Genomics Details

2.16.2 Color Genomics Major Business

2.16.3 Color Genomics Product and Services

2.16.4 Color Genomics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.17 Opko Health

2.17.1 Opko Health Details

2.17.2 Opko Health Major Business

2.17.3 Opko Health Product and Services

2.17.4 Opko Health Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.18 Myriad Genetics

2.18.1 Myriad Genetics Details

2.18.2 Myriad Genetics Major Business

2.18.3 Myriad Genetics Product and Services

2.18.3 Myriad Genetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

2.19 Preventiongenetics

2.19.1 Preventiongenetics Details

2.19.2 Preventiongenetics Major Business

2.19.3 Preventiongenetics Product and Services

2.19.4 Preventiongenetics Rare Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Rare Disease Genetic Testing Market Size by Players (2015-2020)

3.2 China Rare Disease Genetic Testing Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Rare Disease Genetic Testing Players Market Share

3.3.2 Top 10 Rare Disease Genetic Testing Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Rare Disease Genetic Testing Market Size by Countries (2015-2020)

4.2 North America Rare Disease Genetic Testing Market Size and Forecast by Countries (2015-2026)

4.3 United States Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

4.4 Canada Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

4.5 Mexico Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Rare Disease Genetic Testing Market Size by Countries (2015-2020)

5.2 Europe Rare Disease Genetic Testing Market Size and Forecast by Countries (2015-2026)

5.3 Germany Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

5.4 France Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

5.5 UK Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

5.6 Russia Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

5.7 Italy Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Regions (2015-2020)

6.2 Asia-Pacific Rare Disease Genetic Testing Market Size and Forecast by Regions (2015-2026)

6.3 China Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

6.4 Japan Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

6.5 Korea Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

6.6 India Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

6.7 Southeast Asia Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Rare Disease Genetic Testing Market Size by Countries (2015-2020)

7.2 South America Rare Disease Genetic Testing Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

7.4 Argentina Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Rare Disease Genetic Testing Revenue by Regions (2015-2020)

8.2 Middle East & Africa Rare Disease Genetic Testing Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

8.4 UAE Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

8.5 Egypt Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

8.6 South Africa Rare Disease Genetic Testing Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Rare Disease Genetic Testing Market Size and Forecast by Type (2015-2025)

9.1.1 Global Rare Disease Genetic Testing Market Size by Type (2015-2020)

9.1.2 Global Rare Disease Genetic Testing Market Size Forecast by Type (2020-2025)

9.2 China Rare Disease Genetic Testing Market Size and Forecast by Type (2015-2025)

9.2.1 China Rare Disease Genetic Testing Market Size by Type (2015-2020)

9.2.2 China Rare Disease Genetic Testing Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Rare Disease Genetic Testing Market Size and Forecast by Application (2015-2025)

10.1.1 Global Rare Disease Genetic Testing Market Size by Application (2015-2020)

10.1.2 Global Rare Disease Genetic Testing Market Size Forecast by Application (2020-2025)

10.2 China Rare Disease Genetic Testing Market Size and Forecast by Application (2015-2025)

10.2.1 China Rare Disease Genetic Testing Market Size by Application (2015-2020)

10.2.2 China Rare Disease Genetic Testing Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Rare Disease Genetic Testing Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Rare Disease Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Rare Disease Genetic Testing Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Rare Disease Genetic Testing Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Rare Disease Genetic Testing Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Rare Disease Genetic Testing Revenue Share by Regions (2015-2020)

Table 7. Global Rare Disease Genetic Testing Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Rare Disease Genetic Testing Revenue Market Share by Regions (2020-2025)

Table 9. Global Rare Disease Genetic Testing Market Size and Growth Estimation in Various Scenarios in 2020

Table 10. Quest Diagnostics Corporate Information, Location and Competitors

Table 11. Quest Diagnostics Major Business

Table 12. Quest Diagnostics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 13. Quest Diagnostics SWOT Analysis

Table 14. Quest Diagnostics Rare Disease Genetic Testing Product and Solutions

Table 15. Quest Diagnostics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 16. Ambry Genetics Corporate Information, Location and Competitors

Table 17. Ambry Genetics Major Business

Table 18. Ambry Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2018-2019)

Table 19. Ambry Genetics SWOT Analysis

Table 20. Ambry Genetics Rare Disease Genetic Testing Product and Solutions

Table 21. Ambry Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 22. 3billion Corporate Information, Location and Competitors

Table 23. 3billion Major Business

Table 24. 3billion Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 25. 3billion SWOT Analysis

Table 26. 3billion Rare Disease Genetic Testing Product and Solutions

Table 27. 3billion Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 28. Centogene Corporate Information, Location and Competitors

Table 29. Centogene Major Business

Table 30. Centogene Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 31. Centogene SWOT Analysis

Table 32. Centogene Rare Disease Genetic Testing Product and Solutions

Table 33. Centogene Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 34. Strand Life Sciences Corporate Information, Location and Competitors

Table 35. Strand Life Sciences Major Business

Table 36. Strand Life Sciences Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 37. Strand Life Sciences SWOT Analysis

Table 38. Strand Life Sciences Rare Disease Genetic Testing Product and Solutions

Table 39. Strand Life Sciences Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 40. Invitae Corporation Corporate Information, Location and Competitors

Table 41. Invitae Corporation Major Business

Table 42. Invitae Corporation Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 43. Invitae Corporation SWOT Analysis

Table 44. Invitae Corporation Rare Disease Genetic Testing Product and Solutions

Table 45. Invitae Corporation Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 46. Macrogen Corporate Information, Location and Competitors

Table 47. Macrogen Major Business

Table 48. Macrogen Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 49. Macrogen SWOT Analysis

Table 50. Macrogen Rare Disease Genetic Testing Product and Solutions

Table 51. Macrogen Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 52. Eurofins Scientific Corporate Information, Location and Competitors

Table 53. Eurofins Scientific Major Business

Table 54. Eurofins Scientific Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 55. Eurofins Scientific SWOT Analysis

Table 56. Eurofins Scientific Rare Disease Genetic Testing Product and Solutions

Table 57. Eurofins Scientific Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 58. Arup Laboratories Corporate Information, Location and Competitors

Table 59. Arup Laboratories Major Business

Table 60. Arup Laboratories Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 61. Arup Laboratories SWOT Analysis

Table 62. Arup Laboratories Rare Disease Genetic Testing Product and Solutions

Table 63. Arup Laboratories Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 64. Perkin Elmer Corporate Information, Location and Competitors

Table 65. Perkin Elmer Major Business

Table 66. Perkin Elmer Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 67. Perkin Elmer SWOT Analysis

Table 68. Perkin Elmer Rare Disease Genetic Testing Product and Solutions

Table 69. Perkin Elmer Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 70. Coopersurgical Corporate Information, Location and Competitors

Table 71. Coopersurgical Major Business

Table 72. Coopersurgical Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 73. Coopersurgical SWOT Analysis

Table 74. Coopersurgical Rare Disease Genetic Testing Product and Solutions

Table 75. Coopersurgical Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 76. LabCorp Corporate Information, Location and Competitors

Table 77. LabCorp Major Business

Table 78. LabCorp Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 79. LabCorp SWOT Analysis

Table 80. LabCorp Rare Disease Genetic Testing Product and Solutions

Table 81. LabCorp Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 82. Baylor Genetics Corporate Information, Location and Competitors

Table 83. Baylor Genetics Major Business

Table 84. Baylor Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 85. Baylor Genetics SWOT Analysis

Table 86. Baylor Genetics Rare Disease Genetic Testing Product and Solutions

Table 87. Baylor Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 88. Fulgent Genetics Corporate Information, Location and Competitors

Table 89. Fulgent Genetics Major Business

Table 90. Fulgent Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 91. Fulgent Genetics SWOT Analysis

Table 92. Fulgent Genetics Rare Disease Genetic Testing Product and Solutions

Table 93. Fulgent Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 94. Progenity Corporate Information, Location and Competitors

Table 95. Progenity Major Business

Table 96. Progenity Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 97. Progenity SWOT Analysis

Table 98. Progenity Rare Disease Genetic Testing Product and Solutions

Table 99. Progenity Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 100. Color Genomics Corporate Information, Location and Competitors

Table 101. Color Genomics Major Business

Table 102. Color Genomics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 103. Color Genomics SWOT Analysis

Table 104. Color Genomics Rare Disease Genetic Testing Product and Solutions

Table 105. Color Genomics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 106. Opko Health Corporate Information, Location and Competitors

Table 107. Opko Health Major Business

Table 108. Opko Health Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 109. Opko Health SWOT Analysis

Table 110. Opko Health Rare Disease Genetic Testing Product and Solutions

Table 111. Opko Health Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 112. Myriad Genetics Rare Disease Genetic Testing Type and Application

Table 113. Myriad Genetics Major Business

Table 114. Myriad Genetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 115. Myriad Genetics SWOT Analysis

Table 116. Myriad Genetics Rare Disease Genetic Testing Product and Solutions

Table 117. Myriad Genetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 118. Preventiongenetics Corporate Information, Location and Competitors

Table 119. Preventiongenetics Major Business

Table 120. Preventiongenetics Rare Disease Genetic Testing Total Revenue (USD Million) (2017-2018)

Table 121. Preventiongenetics SWOT Analysis

Table 122. Preventiongenetics Rare Disease Genetic Testing Product and Solutions

Table 123. Preventiongenetics Rare Disease Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 124. Global Rare Disease Genetic Testing Revenue (USD Million) by Players (2015-2020)

Table 125. Global Rare Disease Genetic Testing Revenue Share by Players (2015-2020)

Table 126. Key Players Rare Disease Genetic Testing Revenue (USD Million) in China (2015-2020)

Table 127. Key Players Rare Disease Genetic Testing Revenue Share in China (2015-2020)

Table 128. North America Rare Disease Genetic Testing Revenue (USD Million) by Countries (2015-2020)

Table 129. North America Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)

Table 130. North America Rare Disease Genetic Testing Revenue (USD Million) by Countries (2020-2026)

Table 131. North America Rare Disease Genetic Testing Revenue Market Share by Countries (2020-2026)

Table 132. Europe Rare Disease Genetic Testing Revenue (USD Million) by Countries (2015-2020)

Table 133. Europe Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)

Table 134. Europe Rare Disease Genetic Testing Revenue (USD Million) by Countries (2020-2026)

Table 135. Europe Rare Disease Genetic Testing Revenue Market Share by Countries (2020-2026)

Table 136. Asia-Pacific Rare Disease Genetic Testing Revenue (USD Million) by Countries (2015-2020)

Table 137. Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)

Table 138. Asia-Pacific Rare Disease Genetic Testing Revenue (USD Million) by Countries (2020-2026)

Table 139. Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Countries (2020-2026)

Table 140. South America Rare Disease Genetic Testing Revenue (USD Million) by Countries (2015-2020)

Table 141. South America Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)

Table 142. South America Rare Disease Genetic Testing Revenue (USD Million) by Countries (2020-2026)

Table 143. South America Rare Disease Genetic Testing Revenue Market Share by Countries (2020-2026)

Table 144. Middle East & Africa Rare Disease Genetic Testing Revenue (USD Million) by Countries (2015-2020)

Table 145. Middle East & Africa Rare Disease Genetic Testing Revenue Market Share by Countries (2015-2020)

Table 146. Middle East & Africa Rare Disease Genetic Testing Revenue (USD Million) by Countries (2020-2026)

Table 147. Middle East & Africa Rare Disease Genetic Testing Revenue Market Share by Countries (2020-2026)

Table 148. Global Rare Disease Genetic Testing Revenue (USD Million) by Type (2015-2020)

Table 149. Global Rare Disease Genetic Testing Revenue Share by Type (2015-2020)

Table 150. Global Rare Disease Genetic Testing Revenue Forecast by Type (2020-2025)

Table 151. Global Rare Disease Genetic Testing Market Share Forecast by Type (2020-2025)

Table 152. China Rare Disease Genetic Testing Revenue (USD Million) by Type (2015-2020)

Table 153. China Rare Disease Genetic Testing Revenue Share by Type (2015-2020)

Table 154. China Rare Disease Genetic Testing Revenue Forecast by Type (2020-2025)

Table 155. China Rare Disease Genetic Testing Market Share Forecast by Type (2020-2025)

Table 156. Global Rare Disease Genetic Testing Revenue (USD Million) by Application (2015-2020)

Table 157. Global Rare Disease Genetic Testing Revenue Share by Application (2015-2020)

Table 158. Global Rare Disease Genetic Testing Revenue Forecast by Application (2020-2025)

Table 159. Global Rare Disease Genetic Testing Market Share Forecast by Application (2020-2025)

Table 160. China Rare Disease Genetic Testing Revenue (USD Million) by Application (2015-2020)

Table 161. China Rare Disease Genetic Testing Revenue Share by Application (2015-2020)

Table 162. China Rare Disease Genetic Testing Revenue Forecast by Application (2020-2025)

Table 163. China Rare Disease Genetic Testing Market Share Forecast by Application (2020-2025)

Table 164.List of Figures

Table 165. Rare Disease Genetic Testing Picture

Table 166. Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Table 167. Global Rare Disease Genetic Testing Revenue Market Share by Type in 2019

Table 168. Next-Generation Sequencing (NGS) Picture

Table 169. Array Technology Picture

Table 170. PCR-based Testing Picture

Table 171. Fluorescence in Situ Hybridization (FISH) Picture

Table 172. Sanger Sequencing Picture

Table 173. Karyotyping Picture

Table 174. Others Picture

Table 175. Rare Disease Genetic Testing Revenue Market Share by Application in 2019

Table 176. Research Laboratories and CROs Picture

Table 177. Diagnostic Laboratories Picture

Table 178. Hospitals and Clinics Picture

Table 179. Others Picture

Table 180. Global Rare Disease Genetic Testing Revenue and Growth Rate (2015-2025) (USD Million)

Table 181. Global Rare Disease Genetic Testing Market Size Share by Regions (2015-2025)

Table 182. Global Rare Disease Genetic Testing Market Size Share by Regions in 2019

Table 183. Global Rare Disease Genetic Testing Revenue Market Share by Regions (2020-2025)

Table 184. North America Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 185. Europe Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 186. Asia-Pacific Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 187. South America Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 188. Middle East & Africa Rare Disease Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 189. Global Rare Disease Genetic Testing Revenue Share by Players in 2019

Table 190. Global Top 5 Players Rare Disease Genetic Testing Revenue Market Share in 2019

Table 191. Top 10 Players Rare Disease Genetic Testing Revenue Market Share in Global Market in 2019

Table 192. Global Rare Disease Genetic Testing Market Size (USD Million) by Type (2015-2025)

Table 193. Global Rare Disease Genetic Testing Market Size Share by Application (2015-2025)

Table 194. North America Rare Disease Genetic Testing Market Size Share by Countries (2015-2025)

Table 195. North America Rare Disease Genetic Testing Market Size Share by Countries in 2019

Table 196. United States Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 197. Canada Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 198. Mexico Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 199. Europe Rare Disease Genetic Testing Market Size Share by Countries (2015-2025)

Table 200. Europe Rare Disease Genetic Testing Market Size Share by Countries in 2019

Table 201. Germany Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 202. France Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 203. Russia Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 204. Italy Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 205. Spain Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 206. UK Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 207. Asia Rare Disease Genetic Testing Market Size Share by Countries (2015-2025)

Table 208. Asia Rare Disease Genetic Testing Market Size Share by Countries in 2019

Table 209. China Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 210. Japan Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 211. Korea Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 212. India Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 213. Southeast Asia Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 214. South America Rare Disease Genetic Testing Market Size Share by Countries (2015-2025)

Table 215. South America Rare Disease Genetic Testing Market Size Share by Countries in 2019

Table 216. Brazil Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 217. Argentina Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 218. Middle East & Africa Rare Disease Genetic Testing Market Size Share by Countries (2015-2025)

Table 219. Middle East & Africa Rare Disease Genetic Testing Market Size Share by Countries in 2019

Table 220. Saudi Arabia Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 221. UAE Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 222. Egypt Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 223. South Africa Rare Disease Genetic Testing Market Size (USD Million) and Forecast (2015-2025)

Table 224. Global Rare Disease Genetic Testing Revenue Share by Type (2015-2020)

Table 225. China Rare Disease Genetic Testing Revenue Share by Type (2015-2020)

Table 226. Global Rare Disease Genetic Testing Revenue Share by Application (2015-2020)

Table 227. China Rare Disease Genetic Testing Revenue Share by Application (2015-2020)